Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ling Gui Zhu Gan Granules is a modern Traditional Chinese Medicine (TCM) preparation derived from the classic formula Ling Gui Zhu Gan Tang, originally documented in Zhang Zhongjing's "Synopsis of the Golden Chamber" (《金匮要略》) from the Han Dynasty. It is composed of four key herbal ingredients: Fuling (茯苓), Guizhi (桂枝), Baizhu (白术), and Gancao (甘草). The drug functions primarily by warming yang, transforming retained fluid (温阳化饮), strengthening the spleen, and promoting diuresis (健脾利湿). Modern pharmacological research suggests its mechanism involves regulating water metabolism and influencing the transforming growth factor-beta 1 (TGF-β1)/Smads signaling pathway, which is implicated in conditions like myocardial fibrosis. It is indicated for various conditions characterized by retained fluid (痰饮证), including certain cardiovascular, respiratory, digestive, endocrine, and urinary system disorders. It has received marketing approval in China as a pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ling Gui Zhu Gan Granules.